International Journal of Homoeopathic Sciences

Background: Alopecia areata is a chronic, relapsing, non-scarring autoimmune disorder characterized by patchy hair loss, with substantial psychosocial impact in pediatric populations. While conventional treatments are often limited by side effects or incomplete response, individualized homeopathic intervention offers a holistic, patient-centered approach. This case report explores the therapeutic role of Carcinosin in a pediatric case of alopecia areata, with treatment outcomes quantitatively evaluated using validated clinical tools.

Case Presentation: A pre-adolescent female presented with multiple alopecic patches over the parietal and occipital scalp regions. The disease exhibited gradual progression over two years, with no associated inflammation or pruritus. The case was managed with individualized homeopathic prescribing, guided by a detailed constitutional assessment highlighting suppressed anger, fear of rejection, high sensitivity to reprimand, fastidious traits, and specific food cravings. Carcinosin was selected as the constitutional remedy.

Methods: The Severity of Alopecia Tool and Ludwig Hair Loss Scale were employed at baseline and at successive monthly follow-ups to objectively measure hair loss and regrowth patterns. Additional assessment included emotional and behavioral parameters relevant to the case totality.

Results: Over a 10-month follow-up period, a progressive and quantifiable reduction in the Severity of Alopecia Tool score was observed, from an initial estimate of 90–95% hair loss to less than 10% residual thinning in the affected regions. The Ludwig scale also demonstrated consistent downward staging. Concurrent improvement in psychological symptoms, including reduced anger outbursts, diminished fear-related behaviors, and resolution of premenstrual complaints, was noted.

Conclusion: This case illustrates the potential role of individualized homeopathic therapy in the management of pediatric alopecia areata, supported by objective, standardized assessment tools. Quantitative monitoring using the Severity of Alopecia Tool and Ludwig Scale enabled reliable documentation of clinical progress, warranting further research through controlled studies.